Enantioselective C–H bond functionalization under Co(III)-catalysis

Bholanath Garai , Abir Das , Doppalapudi Vineet Kumar and Basker Sundararaju *
Department of Chemistry, Indian Institute of Technology Kanpur, Kanpur, Uttar Pradesh – 208016, India. E-mail: basker@iitk.ac.in

Received 30th October 2023 , Accepted 26th February 2024

First published on 27th February 2024


Abstract

While progress in enantioselective C–H functionalization has been accomplished by employing 4d and 5d transition metal-based catalysts, the rapid depletion of these metals in the earth's crust poses a serious threat to making these protocols sustainable. On the other hand, because of their unique reactivity, low toxicity, and high earth abundance, newer strategies utilizing affordable 3d transition metals have come to the forefront. Among the first-row transition metals, high-valent cobalt has recently attracted a lot of attention for catalytic C–H functionalization with mono and bidentate directing groups. This approach was extended for asymmetric catalysis due to a fairly thorough knowledge of its catalytic cycles. Four major themes have been investigated as a result of this insight: (1) rational design of a chiral Cp#Co(III)-catalyst, (2) chiral carboxylic acid with achiral Cp*Co(III)-catalysts using monodentate directing groups, (3) cobalt/salox-based systems, and (4) cobalt/chiral phosphoric acid-based hybrid systems with bidentate directing groups. Herein, we highlight the recent developments in high-valent cobalt-catalyzed enantioselective C–H functionalization up to October 2023, with the strong belief that the current state-of-the-art can attract considerable interest in the synthetic community, encouraging discoveries in the evolving landscape of asymmetric catalysis.


image file: d3cc05329f-p1.tif

Bholanath Garai

Bholanath Garai received his BSc from Midnapore College and MSc from the Indian Institute of Technology, Madras (IITM) in 2019. His MSc research was carried out under the supervision of Prof. Mahiuddin Baidya at IIT Madras, where he studied [Ru]-catalyzed C–H functionalization of carboxylic acids. Then, he moved to IIT Kanpur to pursue his PhD degree under the supervision of Prof. Basker Sundararaju in 2019. His research focuses on achiral Cp*Co(III)/CCA-catalyzed enantio-selective C–H Functionalization.

image file: d3cc05329f-p2.tif

Abir Das

Abir Das received his BSc from Garhbeta College, Vidyasagar University, West Bengal, and his MSc from Indian Institute of Technology (IIT) Madras in 2020. During his MSc, he worked with Prof. M. Jeganmohan in the development of [Rh]-catalyzed C–H bond functionalization for the completion of his master's thesis. Then, he moved to IIT Kanpur to pursue his PhD degree under the supervision of Prof. Basker Sundararaju in 2020. His research focuses on cobalt-catalyzed enantioselective C–H Bond functionalization.

image file: d3cc05329f-p3.tif

Doppalapudi Vineet Kumar

Doppalapudi Vineet Kumar received his BS–MS dual degree from the IISER Thiruvananthapuramuram in 2019. During his stay at IISER TVM, he was involved with various projects under the supervision of Dr A. Kaliyamoorthy, and subsequently, he spent one year on a project titled Directed Site-Selective C–H Functionalization of Aromatic and Heteroaromatic Precursors in the same research group. He then moved to IIT Kanpur to pursue his PhD degree under the supervision of Prof. Basker Sundararaju in 2020. His research focuses on transition metal-catalyzed site-selective C–H bond functionalization.

image file: d3cc05329f-p4.tif

Basker Sundararaju

Basker Sundararaju obtained his PhD in 2011 from Université de Rennes1, France, under the guidance of Dr Mathieu Achard and Dr Christian Bruneau. Subsequently, he worked with Prof. Alois Fürstner at the MPI für Kohlenforschung, Germany, as a post-doctoral fellow supported by an Alexander Von Humboldt fellowship. In Oct 2013, he began his independent career at the Indian Institute of Technology Kanpur, India, as an Assistant Professor, and subsequently, was promoted to the rank of Professor in 2022. He is a recipient of the Thieme Journal Award, Merck Young Scientist, and Fellow of Royal Society of Chemistry. His research interest primarily focuses on developing base-metal catalysts for region-, stereo- and enantioselective transformations.


1. Introduction

Since the pioneering work of Murahashi in 1955 on low-valent cobalt–carbonyl catalyzed C–H bond functionalization,1 a cobalt–carbonyl dimer has been used either as a catalyst or carbonyl source for various transformations including carbonylation,2 hydroformylation,3 Pauson–Khand (PK reaction),4 hydrovinylation reactions etc. After a few decades, low-valent cobalt based on Cp*Co(I) was utilized for the hydroacylation of aldehydes with alkenes.5a A couple of decades later, Yoshikai,5b Nakamura6 and Ackermann7a demonstrated the use of in situ-formed low-valent cobalt complexes for C–H bond functionalization starting from Co(II) precursors and organometallic reagents (Scheme 1a). However, the use of high-valent cobalt for catalytic C–H bond functionalization was not realized until the work of Matsunaga–Kanai using Cp*Co(III)-catalysts (method A)7b and Daugulis’ work on ortho C–H bond functionalizations using commercially available Co(II) salts (method B) (Scheme 1c).7c While the former method proceeds through piano-stool cobaltacycles based on Cp*Co directed by monodentate coordinating groups, the latter method operates through the in situ-generated octahedral cobaltacycles with bidentate directing groups. Both these methods have been explored intensely by many researchers over the last decade.8a During this period, stoichiometric experiments and detailed mechanistic investigations have also been carried out to obtain better clarity on the catalytic cycle. Furthermore, the requirement of a stoichiometric amount of a metal oxidant such as Mn(III) or Ag(I) with method B is circumvented by using cobalt/electricity or cobalt/photosensitizer with O2 as the oxidant.8b–d These developments over the last decade have paved the way to developing chiral catalytic systems based on high-valent cobalt for asymmetric C–H bond functionalization. This article focuses on the recent developments utilizing high-valent cobalt for asymmetric C–H bond functionalization. Hence, asymmetric transformations utilizing low-valent cobalt operating either through the inner sphere or outer sphere, and high-valent cobalt operating through the outer sphere mechanism are beyond the scope of this article.9a,b
image file: d3cc05329f-s1.tif
Scheme 1 An overview of asymmetric C–H functionalization.

2. Chiral Cp-ligands in asymmetric C–H bond functionalization

Inspired by the work of Vollhardt9c,f and Halterman (Scheme 1b),9d–f Cramer's group developed a series of rationally designed chiral cyclopentadienyl ligands for asymmetric C–H bond functionalization with Rh(I)-precatalysts.10 Cramer and co-workers demonstrated synthesis of both non-C2-symmetric and C2-symmetric chiral cyclopentadienyl ligands and their relevant complexes with Rh(I) and explored a variety of enantioselective C–H bond functionalizations.12 Later, these chiral ligands were also utilized with other metals such as [Ir], [Ru], [Rh], and [Sc] for asymmetric C–H bond functionalizations, which are not covered in this article.11–13 In continuation of the systematic work on chiral Cp#Rh(I)-catalysts (“#” in the superscript refers to substitutions other than penta-methyl on the Cp system) for C–H bond functionalization by Cramer, and the parallel development of the Cp*Co(III)-catalytic system for C–H bond functionalization further drove the authors to isolate the first chiral Cp#Co(III)-complexes and utilize them as catalysts for enantioselective C–H functionalization.14 Cramer and co-workers demonstrated that it is essential to fine-tune the electronic and steric factors at the Cp ring to get high enantiomeric excess. The trisubstituted CptBuCo(III) catalyst [Co-7] provides an interesting catalytic outcome with 99% ee (Scheme 2).14
image file: d3cc05329f-s2.tif
Scheme 2 Chiral Cp#Co(III)-complexes for enantioselective C–H functionalization.

2.1. C–C bond formation

Utilizing these chiral Cp#Co catalysts, Cramer's group explored C–H bond annulation with N-chlorobenzamide and alkenes in the presence of chiral Co(III)-catalysts, and achieved the chiral dihydroisoquinolones in moderate yields and with good enantioselectivity (Schemes 2c and 8a–d). Interestingly, increasing the substituents in the cyclopentadienyl ligand decreases the [Co]–CO stretching frequency, and the substituted Cp moiety can influence the dihedral angle and provide an optimal chiral pocket for asymmetric induction (Scheme 2c).14

In 2021, the same group reported a chiral CpiPrCo(III)-complex [Co-8] for enantioselective intermolecular carbo-amidation of N-phenoxy acetamides with alkenes, and achieved the target products with excellent ee in moderate-to-good yields (11a, 12b) (Scheme 3a).15 The protocol was amenable to various N-phenoxy acetamides and a wide variety of alkenes like acrylates and bicyclic olefins. Subsequently, Cramer's group further extended the scope of the chiral Cp#Co(III) catalysts for three-component coupling of arylpyrazole (13) with aldehyde (14), and activated olefins (15) (Scheme 3b).16


image file: d3cc05329f-s3.tif
Scheme 3 Chiral Cp#Co(III)-catalyzed enantioselective C–H functionalization.

This strategy provided access to molecules with contiguous stereogenic centres and the expected molecules were isolated with diastereoselectivity ranging from 7[thin space (1/6-em)]:[thin space (1/6-em)]1 to 10[thin space (1/6-em)]:[thin space (1/6-em)]1, besides high enantioselectivity. Such multicomponent reaction did not provide any desired results with the Cp#Rh(III)-catalyst highlighting the unique reactivity associated with a chiral Cp#Co(III)-catalytic system.16

Later, You and co-workers demonstrated the utilization of the chiral Cp#Co(III)-catalytic system for asymmetric ring-opening of strained bicyclic 7-oxa (or aza) benzonorbornadienes (18) with pyrimidyl indoles (17). The scope of indoles and 7-oxabenzonorbornadienes was excellent and the products were isolated in good-to-excellent yields with ee up to 99% (19a and b) (Scheme 4).17 They proposed that the migratory insertion of olefins followed by enantiodetermining cis-β-heteroatom elimination furnishes the expected product with complete cis-selectivity. However, the replacement of the chiral Cp#Co(III)-catalyst [(R)-Co-7] by the racemic Cp*Co(III)-catalyst provided the trans-selective product, indicating that the elimination pathway may depend on the coordination environment. The ring-opening pathway through the nucleophilic attack of [Co]–C to the strained C–O bond could be responsible for the trans-selectivity in the case of the latter (Scheme 4).17


image file: d3cc05329f-s4.tif
Scheme 4 Chiral Cp#Co(III)-catalyzed asymmetric ring opening of 7-oxa/aza benzo norbornadiene.

3. Asymmetric C–H bond functionalization using chiral carboxylic acids (CCAs)

Transition-metal-catalyzed C–H functionalization largely depends on the steric and electronic nature of the metal as well as the coordination environment of the associated ligands. So, the judicious choice of ligands must influence the C–H cleavage as well as desymmetrize the molecule.18 In this regard, the [M–C] bond formation through C–H bond activation with Cp*M(III) is largely driven by the carboxylate ligands and their assistance in concerted-metalation and deprotonation (CMD).19 Hence, carboxylate ligands play a vital role in achieving the desired metallacycle either in situ or through isolation. In addition, these carboxylate ligands also act as counter ions by stabilizing the cationic group 9 metal species formed in situ, sometimes providing sufficient protons in the proto-demetalation step.18

In this regard, chiral carboxylic acids (CCAs) in combination with achiral Cp*M(III)-complexes could be exploited for enantioselective transformations to generate conformationally flexible chiral geometry around the metal centre, which can induce chirality to the target molecules.18,20,33a

To validate this concept, Chang's group explored the use of O,O-dipivaloyl-L-tartaric acid as a chiral carboxylic acid along with Cp*Ir(III) for asymmetric C–H bond functionalization with the observed enantioselectivity of 66[thin space (1/6-em)]:[thin space (1/6-em)]34.21 Subsequently, Cramer and co-workers reported enantioselective C–H bond activation with chiral Cp# ligands in cooperation with chiral carboxylic acids, where the presence of chiral Cp-ligands was essential in achieving the high enantioselectivity.22

A closer look at the coordination environment of the Cp*M(III) complexes revealed that only one coordination site is available for the chiral carboxylate to bind to the metal during the C–H cleavage step.23 Hence, the choice of chiral carboxylic acids and their steric environment around the metal is crucial in achieving high enantioinduction using Cp*M(III) with chiral carboxylic acid catalytic systems.

3.1. C–C bond formation

In 2018, Ackermann and co-workers reported the first example of cobalt(III)-catalyzed regio- and enantioselective C–H alkylation of N-protected indoles in moderate yields and with a maximum ee of 84%.24 The protocol was applied to a variety of protected indole derivatives and alkenes having challenging functionalities like –OTf (22a), –CO2Et (22b), and –OH (22c), resulting in alkylated products in Markovnikov fashion. Experimental and theoretical studies have revealed that the proto- demetallation step is the key to the enantio-determining step by rationally designed C2-symmetric chiral carboxylic acid CCA 1 (Scheme 5a).24
image file: d3cc05329f-s5.tif
Scheme 5 Achiral Cp*Co(III)/CCA-catalyzed enantioselective C(sp2)–H hydroarylation.

During the same period, Matsunaga and co-workers demonstrated the use of BINOL-derived chiral carboxylic acid (CCA 2) in the presence of the achiral Cp*Co(III)-catalyst for asymmetric addition of an alkenyl–[Co] bond to maleimides (24) with indole in a moderately enantioselective manner.

The stereoselective insertion of a [Co–C] moiety of N-protected indole (23) to maleimides (24) was controlled by the CCA. The reported catalytic conditions provided moderate enantiomeric excess, which may be likely due to the enolization of the α-methylene hydrogen; however, the protocol afforded excellent yields of the corresponding product (Scheme 5b).25

In 2021, Shi's group reported a Cp*Co(III)-catalyzed highly enantioselective hydroarylation of un-activated terminal alkenes (26) with N-protected indoles (17). They displayed a wide range of substrate tolerability in moderate-to-excellent yields and ee of up to 98%. They demonstrated that N-phthaloyl-protected non-canonical bulky amino acids were effective in inducing high enantiomeric excess in product (CCA 3). The developed protocol was effective for the intramolecular annulation of N-protected pyrroles and indole in moderate-to-good yields with good enantiomeric excess (27b). They reasoned that the π–π stacking between the electron-deficient directing group and electron-rich amino acid can stabilize the enantio-determining transition state and create a specific chiral pocket for high enantio-induction (TS-2) (Scheme 5c).26

Recently, Ackermann and co-workers introduced a data-driven model to identify efficient CCAs for enantio- and diastereoselective C–H alkylation of indoles under achiral cobalt catalysis. The machine learning approach assisted them in identifying the favourable transition state with effective CCAs in a short time and subsequent validation of those results led to high enantio-induction. They provided a library of C-central and C–N axial chiral molecules in excellent yields and ee of up to 95% (29a–d) (Scheme 5d).27

3.2. C–N bond formation

In all the above cases the chiral carboxylic acids were found to assist in the CMD process to generate an achiral cyclo-metalated complex as well as act as a proton source to the substrate in the proto-demetalation step in an enantioselective fashion to generate the chiral product (Scheme 5). But in asymmetric C–N bond-forming reactions, CCAs assist in the CMD process to generate a chiral organometallic species (Scheme 1), which upon subjecting to a suitable aminating reagent, provides the desired product (Scheme 6 and 7).
image file: d3cc05329f-s6.tif
Scheme 6 Achiral Cp*Co(III)/CCA-catalyzed enantioselective C(sp3)–H amidation.

image file: d3cc05329f-s7.tif
Scheme 7 Achiral Cp*Co(III)/CCA-catalyzed enantioselective C(sp2)–H amidation.

In this regard, in 2019, Matsunaga and co-workers illustrated the first example of a hybrid catalytic system for the enantioselective C(sp3)–H amidation of thioamides under the Cp*Co(III)/CCA catalytic system.28 An achiral Cp*Co(III)-catalyst in combination with amino acid-derived CCA 5 leads to the expected amidated product in good enantiomeric excess. The scope of the reaction was very general providing the target molecules in 50–99% yields and up to 88% ee (32a to 32d). Also, sterically bulkier CptBuCo(III) with CCA 5 turned out to be the most effective combination to deliver the expected molecules with moderate-to-excellent yields and good ee (Scheme 6a). The scope of the reaction was extended to a variety of thioamides (33) and dioxazolone derivatives (31). Moreover, non-cyclic amides were also amenable resulting in good ee and good yield (32b) (Scheme 6a).28 In addition to the exploration of C–N bond formation, a parallel effort was put forth to apply for asymmetric C–C bond formation.

In 2019, Matsunaga et al. exploited the inherent chirality associated with ferrocenes. Rationally designed new chiral carboxylic acids based on 1,2-disubstituted chiral ferrocene carboxylic acids that ensured only enantioselective C–H activation with the achiral Cp*Co(III)-complex were also effective in achieving high enantiomeric excess under mild conditions. The systematic study allowed the authors to discover a series of new planar chiral carboxylic acids CCA 6–9, which can be easily accessed using the reported C–H arylation strategy (Scheme 6b). Among the CCAs screened, CCA 9 was found to be the best candidate for both reactivity and enantioselectivity (Scheme 6b).29

In 2019, Shi's group reported a thioamide-directed C(sp2)–H amidation for the construction of planar chiral molecules under Cp*Co(III)-catalysis using commercially available monoprotected amino acid (D)-Bz-Hpg–OH (CCA 10) as a chiral carboxylic acid. The isolated products were obtained in excellent yields with observed enantio-induction of up to 77.5[thin space (1/6-em)]:[thin space (1/6-em)]22.5 er (Scheme 7a).30 The coordination of thioamide-directed C–H activation is crucial, and it turns out to be the enantio-determining step. Among the solvents screened, ethanol was found to be the best solvent to eliminate the other background reactions.

Subsequently, Matsunaga et al. reported a sulfoximine-directed enantioselective synthesis of benzothiadiazine-1-oxides via C–H activation in a combination of achiral Co(III)-complex and CCA 11. The newly designed (S)-BINOL-derived pseudo-C2-symmetric H8-binaphthyl CCA provided the target products in high yields and with an enantiomeric ratio of up to 98[thin space (1/6-em)]:[thin space (1/6-em)]2 (38) (Scheme 7b).31 The protocol was applied to various diarylsulfoximines (37) and dioxazolone derivatives (31) and provided moderate enantioselectivity (38a and 38b). Control experiments and mechanistic investigations suggested that the C–H bond cleavage was the rate-limiting step and the DFT study further confirmed that it was also the enantio-determining step (TS-5) (Scheme 7b).31

Later, Shi's group showcased the use of amide-hydrogen bonded, carboxylate-assisted enantioselective C–H activation of sulfoximines in the presence of achiral Cp*Co(III) and CCA 12. The DFT calculations suggested that the C–H activation was the rate-determining step and free –NH was crucial for the reaction as it involved hydrogen bonding with the amide at the proximal position (TS-6) (Scheme 7c).32

4. Cobalt-bidentate chelation strategy

Over the last few years, we have witnessed the progress of Cp*Co(III)-catalysis in enantioselective C–H functionalization using monodentate directing groups.20,33 Both of the above discussed about the use of chiral Cp# ligands and their cobalt metal complexes, and racemic Cp*Co(III)-catalysts along with CCAs to provide an ideal environment for catalytic asymmetric C–H bond functionalization in one step.33b,34 However, both the approaches have their own limitations. While the former requires the laborious and time-consuming preparation of chiral Cp-ligands and subsequent stabilization of their cobalt complexes, the latter has limited application because of the difficulty in achieving high enantioselectivity due to monodentate coordination of the chiral carboxylic acid and conformational flexibility.20,33–35

In 2014, Daugulis’ group reported a cobalt-catalyzed C–H annulation of alkynes using a bidentate directing group, starting from simple and commercially available cobalt(II) salts.7c Since then a plethora of examples have been reported over the last ten years including the isolation of an active octahedral cobaltacycle [Co-12] involved in the catalytic cycle.36 The close examination of the octahedral cobaltacycle revealed that cobalt was in the +3 oxidation state and bound with one tridentate N, N, C type coordination and N,N-coordination of 8-aminoquinoline as L, and one X-type bidentate spectator ligand along with the solvent at the axial position (Scheme 8a).


image file: d3cc05329f-s8.tif
Scheme 8 Bidentate chelation approach.

Since the spectator ligands in the octahedral complex bind to the metal to stabilize the 6-coordinate geometry, also the spectator ligand stabilizes the Co(I)-intermediate upon reductive elimination.36 These coordination sites can potentially be replaced by external bidentate ligands to enhance the reactivity and selectivity including asymmetric induction (Scheme 8b).

In 2022, Shi's group demonstrated an elegant work of replacing the N,N-spectator ligand of the substrate with an external chiral monoanionic bidentate N,O-ligand based on salicyloxazoline (salox), which can mimic the coordination nature of in situ- generated monoanionic 8-aminoquinoline, and at the same time induce a rigid chiral environment around cobalt (Scheme 8b).35 Shi and co-workers demonstrated that the asymmetric C–H bond annulation was able to achieve chiral molecules using simple, commercially available, inexpensive cobalt(II) salts along with (S)-salox ligand L1 using phosphinamide and alkyne. Shi et al. proposed that the C–H activation is the enantio-determining step and provides the chiral annulated compounds in up to 99% ee. The reaction tolerated various terminal and internal alkynes with electron-donating and withdrawing groups, and the resultant products were obtained with high regio- and enantioselectivities besides high yields (43a–d). Alkynes containing ferrocene, estrone, and pharmaceutical moieties like ezetimibe were amenable to the reaction. Various electronically diverse diaryl phosphinamides were tolerated. Furthermore, a gram-scale reaction was performed to result in product formation with a 97% yield and > 99% ee with 1 mol% loading of the cobalt source (Scheme 9a).35


image file: d3cc05329f-s9.tif
Scheme 9 Asymmetric approach of bidentate chelation for C–H functionalization.

To validate the proposed proof-of-concept, the authors isolated the octahedral complex featuring (S)-L1 and two acetylacetonate (acac) ligands. Among the many possible diastereomers, the authors isolated the octahedral [(Λ/Δ) Co(acac)2((S)-L1)] complex in Λ- and Δ-diastereomers in a 15[thin space (1/6-em)]:[thin space (1/6-em)]1 ratio and both ΛCo and ΔCo complexes were structurally characterized (Scheme 9c). Solvents such as tBuOH and tAmylOH provided the highest ratio of 15[thin space (1/6-em)]:[thin space (1/6-em)]1(Λ/Δ) and they reported that the ratio may vary depending on the solvent employed. Replacement of one acac ligand with phosphinamides featuring 8-aminoquinoline did not change the ratio of the Λ/Δ diastereomers (Scheme 9b) indicating that ΛCo-(SC)-Co-13 is a major diastereomer formed before C–H activation. However, both ΛCo and ΔCo complexes were catalytically active and provided the same annulated molecules without change in the absolute configuration of the isolated chiral product indicating that upon C–H activation, only the major diastereomer formed among other possible diastereomers generated in situ in the reaction. To further ascertain the hypothesis based on the catalytic outcome with ΛCo and ΔCo as catalysts, the authors further explored the isolation of the cobalt complex with the 8-aminoquionline bound phosphinamide as shown in Scheme 9. It is important to highlight that the ligand exchange with acac in Co(acac)2 first occurs with salox L1 and subsequent cyclometallation leads to a ΔCo-(SC)-Co-13 octahedral complex in contrast to the expected retention of the configuration with rac-phosphinamide that leads to ΛCo-(SC)-Co-14. The highly diastereoselective cobaltacycle mer-(SC, SP)-Co-15 (Scheme 9e) (at this stage, it was not clear whether the isolated cobalt complex was Δ or Λ) was isolated with sodium pivalate as the carboxylate source and 4-MeO-Py as the stabilizing ligand starting from racemic phosphinamide, (S)-L1 and Co(II) precursors. According to them, enantio-determining C–H activation results in a mer-(SC, SP)-Co-15 complex as a major diastereomer. However, the energy differences between cobaltacycles such as merCo-(SC, SP)-Co and mer-ΛCo-(SC, SP)-Co and merCo-(SC, SP)-Co and merCo-(SC, RP)-Co are not discussed in detail. Also, Shi and co-workers proposed that major diastereomer (mer-(SC, SP)-Co-15) was stabilized through the π–π interactions between the phenyl groups of L1 and 8- aminoquinoline, and one of the phenyl groups of the phosphinamide upon cyclometallation.

Furthermore, they explained that the steric repulsion between the phenyl group of alkynes and the aryl group bound to phosphorus forced the sterically bulkier aryl group away, resulting in one single regio-isomer as the major one over the other isomers, especially with unsymmetrical internal and terminal alkynes (Scheme 9).35

At that time Niu's group independently discovered an elegant strategy for the synthesis of a C–N axially chiral compound containing an isoquinolinone motif in a single step in combination with Co/salox (L2) catalytic conditions with benzamides bearing a C–7 substituent of quinoline ring with alkynes. The reaction conditions were tolerated for a variety of internal and terminal alkynes and a variety of benzamides with excellent yields of up to 98% and enantioselectivity of up to 98% ee. Interestingly various substituents at C–7 of the quinoline ring allowed access to chiral isoquinolinones with good to excellent yields and enantiomeric excess (46). In addition to that, a mechanistic study indicates that C–N reductive elimination is the stereo-determining step. Also, the resulting product shows a high-temperature resistance for atropostability. The obtained product (46a) was used for Pd-catalyzed C–H functionalization of indole (Scheme 10a).34b


image file: d3cc05329f-s10.tif
Scheme 10 Recent progress of the Co(III)/salox catalytic system.

At the time, the Shi group further extended their initial discovery to other enantioselective C–H activation reactions. For example, C–H alkoxylation and amination was achieved using 8-aminoquinoline-derived diphenylphosphinamide in the presence of chiral salox ligands (L1, 3 or 4) in combination with a Co(II)-salt (Scheme 10b).37 The substrate scope of alcohol, amine, and different diphenylphosphinamides was very general with various functional groups and producing the target product in excellent yields with very high enantio-induction (47 and 49). Mechanistic investigation showed that the chiral octahedral cobaltacycle stabilized with a 4-acetylpyridine ligand was catalytically inactive under oxidant-free conditions even at 120 °C. In the presence of air, the mono alkoxylated product was obtained in 15% yield and 99% ee and also they isolated the bis-alkoxylation product using Ag2CO3 as an oxidant in good yield with 99% ee. These experiments supported the hypothesis that the reaction was proceeding through oxidation-induced reductive elimination pathways and high-valent Co(IV) might be involved, which was earlier proposed by Ackermann and Hong through computational studies (Scheme 10b).38,39

Di-axial or multi-axial chirality was not much explored in the literature and only a few examples were documented in the literature. In 2022, Shi and co-workers disclosed an enantioselective synthesis of atropisomers with vicinal C–N and C–C chiral biaxiality in a single molecule. Judicious choice of benzamide and chiral salox L1 in combination with suitable cobalt salts afforded sterically congested axially chiral molecules in 99% ee with a dr of >7[thin space (1/6-em)]:[thin space (1/6-em)]1 (51a–d). This approach holds a high potential for accessing sterically crowded benzamide derivatives (Scheme 10c).40

In 2023, Niu and co-workers demonstrated the asymmetric synthesis of dihydroisoquinolones using benzamides and alkenes in the presence of a Co/salox (L6 or 7) hybrid catalytic system. The fast kinetics of the reaction afforded the products in just 10 min and the applicability of the protocol was extended to aliphatic, aromatic, symmetric and un-symmetric alkenes, cyclic dienes, and benzamides having –CO2Me, –CF3 and –OMe functionalities in high yields and enantioselectivity. Also, heterocyclic (53a), and aliphatic amides (53b) were amenable to delivering the corresponding enantioenriched products (Scheme 10d).41

Recently, our group demonstrated a reversing of the regioselectivity of asymmetric C–H and N–H bond annulation of diaryl phosphinamides with bromo-alkyne, and a carboxylate nucleophile with the Co/salox (L5) catalytic system. The developed reaction conditions were amenable to a variety of bromo-alkynes (54), and diaryl phosphinamides (41), and the expected products were isolated in good-to-excellent yields with ee up to 99% (55). The catalytically active chiral Oh-cobaltacycle (S)-[Co-16] was isolated and a stoichiometric reaction with alkynyl-bromide resulted in an annulated product with carbon attached to bromine, alpha to the nitrogen atom (56). This vinyl bromide was further subjected to the standard reaction conditions yielding the expected OPiv product (55e) suggesting the involvement of low-valent [CoI] species and the in situ-generated [CoI] species after the annulation underwent oxidative addition with vinyl bromide; subsequently, ligand exchange and reductive elimination gave the expected product (Scheme 10e).42 Furthermore, DFT studies suggested that the energy difference between cobaltacycles such as merCo-(SC, SP)-Co and mer-ΛCo-(SC, SP)-Co was found to be 12.4 kcal mol−1T. The difference in energy between TS-merCo-(SC, SP)-Co orientations is found to be 5.44 kcal mol−1 lower in energy compared to the TS-merCo-(SC, RP)-Co of the phosphorus suggesting that the (S) isomer is more favored and the theoretically predicted ee is found to be 99.9%.

5. Renaissance of asymmetric electrochemical reactions with the cobalt catalytic system

In recent times, electrochemical synthesis has become one of the most popular tools in organic chemistry to access target molecules from available chemical feedstocks.43–48 Moreover, the traceless oxidation of a chemical species using electricity makes the process sustainable and environmentally benign.46 In 1830, Michael Faraday invented the electrolysis of acetic acid with the combination of a cathode and anode.49 In 1847, Kolbe electrolysis of ubiquitous carboxylic acids to generate alkyl radicals was the first example of an organic electrochemical reaction and arguably this was the first example of electricity in organic synthesis.46,50 Recently, 3d transition metal-catalyzed enantioselective electro-organic synthesis has gained immense attention in organic chemistry and has made a renaissance in catalysis.

A closer look at the high-valent cobalt-catalyzed C–H bond functionalization using the bidentate directing group revealed that the use of Mn(III) or Ag(I) as an oxidant in a stoichiometric amount was unavoidable. This was circumvented in recent times either by using electricity as an oxidant or a cobalt catalyst combined with photosensitizers and oxygen under light irradiation. While the former method has been extensively explored by the groups of Ackermann, Lei, and others for C–H bond functionalization, an extension of such strategies for asymmetric C–H bond functionalization, it is in its infancy due to challenges such as (a) conformational stability in [Co]-complexes associated with the ligand, (b) electrolyte interference in the enantio-determining transition state, and (c) unexpected oxidation of functional groups or the substrate in the presence of electricity that may occur in asymmetric electrocatalysis.51,52

With the above challenges in mind, first Ackermann and co-workers reported the electro-oxidative asymmetric C–H activation using a [Co]/salox (L1, 8, or 9) system with various π-coupling partners, amines, and alcohols (Scheme 11).50 The reaction was shown to be highly regio-, stereo-, and chemo- selective to produce P-stereogenic (43, 47 and 58), atroposelective (59), and C-stereogenic (61), molecules in high yields with excellent enantio-induction. Benzamides derived from C7-substituted quinolines (44) were amenable to annulation with alkynes and the expected atropisomeric products were obtained in excellent yields with up to 99% ee.


image file: d3cc05329f-s11.tif
Scheme 11 First asymmetric electrochemical reaction through C–H functionalization.

Besides, various benzamides (52) were also annulated with cyclic alkenes to furnish a group of central chiral molecules (61) in good yields and up to 99.5[thin space (1/6-em)]:[thin space (1/6-em)]0.5 enantiomeric ratio (Scheme 11).50 Around the same time, Shi's group disclosed an electro-oxidative annulation of benzamides and alkenes in the presence of sterically bulky salox (L10) and Co(II)-salts at room temperature. The scope of various α-aryl olefins was suitable for chiral dihydroisoquinolone (c-DHIQO) skeleton synthesis (53).51 Challenging and unbiased α-aliphatic alkenes were not amenable, but a judicious choice of pyridine ligands generated a highly regio- and enantiocontrolled reaction outcome. Notably, in the presence of a 3,4,5-trichloropyridine ligand, a π–π interaction between the benzene of benzamide and benzene of the ligand was crucial to get stable catalytically active organometallic species. The corresponding catalytically active chiral octahedral cobaltacycles were isolated (a) without any stabilizing ligand, (b) with 3,4,5-trichloropyriine, and (c) with MeOH (Scheme 12a).51


image file: d3cc05329f-s12.tif
Scheme 12 Electricity-driven enantioselective C–H functionalization with Co(II)/salox.

The same group further extended their work on electrochemical enantioselective C–H oxygenation of diarylphosphinamides using Co(II)-salt and chiral salox (L1) ligand. A range of alkoxylated chiral phosphinamides were isolated with good yields and up to >99% enantiomeric excess (49c, d). This method obviated the use of a stoichiometric silver oxidant producing hydrogen gas, thereby rendering the process more environmentally friendly. The involvement of the [CoIV] intermediate upon binding with OMe was further supported by cyclic voltammetry (Scheme 12b).52

In continuation of the earlier work, Ackermann's group reported an electrocatalytic enantioselective synthesis of C–N axially chiral amides in combination with Co(II)-salt/chiral salox (L2 or L7) in an undivided cell. The catalytic conditions could be used to access atroposelective amides through C–N axial chirality in a single step (63a–c). Furthermore, the same methodology was applied for the synthesis of a variety of P-stereogenic compounds in excellent yields (up to 99%) and 99% ee (Scheme 12c). This protocol was amenable to diverse electronically and sterically biased benzamides and allenes (64a–c). Also, the protocol was extended to late-stage diversification of drug molecules. The synthetic potential was further extended to a continuous flow reactor setup without any supporting electrolyte yielding the same stereo-electronic product with a slight modification of the reaction conditions (Scheme 12c).53

In 2023, Ling and co-workers documented the electrochemical synthesis of P-stereogenic cyclic phosphinamides (65) with the aid of chiral salicyloxazoline (L1) and cobalt acetate tetrahydrate as an inexpensive catalyst with moderate-to-excellent yields and ee up to 99%. The reported reaction conditions displayed a diverse range of phosphinamides and alkynes with good functional group tolerance. In addition, a good kinetic resolution with an s-factor of up to 347.8 was obtained (Scheme 12d).54

6. Co(II)/chiral phosphoric acid (CPA) system

Spirocyclic chiral ϒ-lactams are important scaffolds in many biologically active molecules.55–58 Also, the chiral quaternary carbon-containing molecules are important in organic chemistry as they can exhibit both axial and point chirality.59a In this context, organocatalytic and catalytic de-aromatic reactions provide a platform to access chiral spirocyclic chiral quaternary carbon motifs in a single kick.59b In the same line, chiral phosphoric acid-catalyzed asymmetric synthesis was widely explored in organocatalysis to access enantioenriched target molecules.60,61 Recently, chiral phosphoric acids have been used in combination with transition metals to induce chirality into the organic molecules in a stereoselective manner.62

In 2021, Shi's group reported a cobalt(II)-catalyzed enantioselective spirocyclization through C–H olefination and spirocyclization in the presence of chiral phosphoric acid (sCPA-1). The reaction was very specific to spirochiral phosphoric acid and the solvent system. The catalytic conditions provided a library of spiro compounds with 41–70% yields and up to 98% ee (67a and b). Also, the methodology was extended to the synthesis of chiral aldose reductase inhibitors in a 60% yield and 91% ee.63 Mechanistic investigation showed that stereochemical 1,4-addition of [Co] might be the enantio-determining step (TS-8) (Scheme 13a).63


image file: d3cc05329f-s13.tif
Scheme 13 Asymmetric [4 + 1] spiro-cyclization using a Co(II)/CPA hybrid system.

Recently, Ackermann and co-workers demonstrated spiro cyclization through electrochemical cobalt-catalyzed C–H activation in the presence of chiral phosphoric acid. Here, (S)-BINOL-derived chiral phosphoric acid was used to carry out the reaction in moderate yield and high enantioselectivity (Scheme 13b).50 Notably, the authors observed the opposite stereoisomer under the combination of electricity and CPA-2 conditions. Furthermore, the ultraviolet-visible spectro-electrochemical analysis provided evidence that the reactions might proceed via the Co(III/IV/II) pathway, and the corresponding intermediate was detected by HRMS (TS-9) (Scheme 13).50

Subsequently, Shi and co-workers developed a new methodology for the desymmetrization of benzyl-protected picolinamides (PAs) through C–H bond annulation in a combination of the Co(II)/salox catalytic system. Fine-tuning of the directing group to picolinyl led to an electronically and sterically similar chiral Oh cobaltacycle [Co-18], which could be exploited for the synthesis of chiral-diaryl methylamine (DAMA) (Scheme 14a).64 A variety of chiral DAMAs were accessed through C–H alkoxylation in the presence of Co(II)-salt and salox (L2) with good-to-excellent ee with moderate-to-excellent yields (69). The reaction proceeds through sequential processes such as desymmetrization, kinetic resolution, and parallel kinetic resolution to afford the expected methoxylated product in an excellent yield (up to 90%) and 99% ee (Scheme 14b). Also, the obtained products were derivatized into value-added molecular architectures (Scheme 14).64


image file: d3cc05329f-s14.tif
Scheme 14 Synthesis of chiral diarylmethylamines by cobalt-catalyzed enantioselective C–H alkoxylation.

C–N axially chiral molecules have applications in the agricultural and medicinal areas; therefore, C–N chiral sulphonamide is a unique skeleton in the broad area of organic synthesis and synthesis of such molecules in an asymmetric manner is holding the attention of the scientific community.65–67 Also, the construction of chiral sultam-based scaffolds was not much explored in the literature. In 2023, Niu and co-workers reported a Co/salox (L6) based catalytic system for C–H bond annulation of sulfonamides with allenes/alkynes with excellent enantiomeric excess and moderate-to-good yields (Scheme 15a).68 The developed methodology was applied to access a variety of chiral sultams in one step (70 and 71). At the same time, they developed a C–N axially chiral hetero-biaryl isoquinolinone skeleton construction via cobalt-catalyzed atroposelective C–H activation/annulation of benzamides and allenes with excellent yields and enantiomeric excess under thermal conditions (Scheme 15b).69 The work was further extended without any external oxidant using an environmentally begin enantioselective electro-organic process (63d).69


image file: d3cc05329f-s15.tif
Scheme 15 C–N axially chiral hetero-biaryl skeleton construction via cobalt-catalyzed atroposelective annulation.

In continuation of their work, the same group further developed an unprecedented synthesis of C–N axially chiral cyclized products of benzamide (44) and isonitriles (72) as a C1 carbon source under the cobalt/salox (L2) catalytic system. The isolated products were accessed with high yields and ee (Scheme 15c).70

We have discussed the construction of C–N axially chiral five- or six-membered N-heterocycle architectures in an atroposelective manner via thermal as well as under electro-oxidative conditions. The construction of C–C and C–N axially chiral frameworks is relatively easy because the rotational barrier about such bonds is sufficiently high in comparison to others. Atropisomerism around the N–N bond is a long-lasting problem in the scientific community, because of the easy epimerisation of the N–N bond. However, judicious choice of substrates might restrict the rotation around N–N and result in atropisomerism.71

Recently, Niu and co-workers established a protocol that renders N–N axially chiral isoquinolinones through cobalt-catalyzed atroposelective C–H activation/annulation. They constructed the N–N axially chiral architectures with excellent ee and yields (76). A variety of benzamides (74) and alkynes (75) were tolerated with excellent efficiencies. Moreover, such complex chiral molecules could be synthesized even in the presence of electrochemical conditions for asymmetric synthesis in a combination of cobalt/salox (L10) catalytic system with high ee and reasonably good yields (76c and d) (Scheme 16).71


image file: d3cc05329f-s16.tif
Scheme 16 Synthesis of atroposelective N–N axially chiral frameworks.

Dynamic kinetic resolution (DKR) is a powerful process to obtain the racemic molecules with a quantitative yield. The process could proceed via two different diastereomeric transition states [Co-20A and Co-20B], which are interconvertible. However, only one transition state [Co-20] provides the favoured product with an energetically favoured transition state.72

In 2023, Shi and co-workers demonstrated an unprecedented cobalt/salox catalytic system for the DKR of racemic biaryls as shown in Scheme 17. The (rac)-biaryl would coordinate to the [Co]/salox (L11) system and generate two diastereomers [Co-20A] and [Co-20B]. More stable transition state [Co-20B] would lead to a chiral octahedral cobaltacycle [Co-20] (C), which subsequently furnishes the expected chiral product (aS)-3 (Scheme 17a).73 This dynamic kinetic asymmetric transformation (DYKAT) was applied to racemic picolinamide-protected biaryl amines with aryl boronic acids under cobalt/salox(L11) hybrid catalytic conditions. The scope of the biaryl and aryl boronic acid derivatives was versatile, tolerating hydroxy (79a), silyl (79b), and terminal alkynes (79c) with excellent enantiomeric excess and moderate-to-excellent yields of the chiral arylated products (Scheme 17b).73


image file: d3cc05329f-s17.tif
Scheme 17 Axially chiral biaryls through atroposelective C–H arylation.

7. Conclusions and perspectives

High-valent cobalt-catalyzed C–H functionalization has witnessed tremendous progress over the last decade. The extension of this chemistry to the asymmetric version is largely dependent on bringing down the reaction temperature, and access to a chiral environment either using a chiral ligand or weakly chelating carboxylates, etc. The pioneering work of Matsunaga and Kanai on utilizing Cp*Co(III)-catalysts with monodentate directing groups, and parallel work by Daugulis on utilizing Co(II)-chemistry with bidentate directing groups provided wide opportunities to functionalize C–H bonds into value-added products in one step. However, the latter method requires a stoichiometric amount of Mn(III) or Ag(I) as an oxidant. This was circumvented by Lei and Ackermann by utilizing electricity as a source of oxidant obviating metal oxidants. During the same time, an alternative route reported by Sundararaju and co-workers applied a dual catalytic approach by combining cobalt and photosensitizers along with oxygen for C–H bond annulation in the absence of any metal oxidant.

While research was exploding with numerous transformations utilizing both mono- and bidentate directing groups under two different Co(III) catalytic systems, the development of chiral carboxylic acid combined with Cp*Rh(III) or Cp*Ir(III) for asymmetric C–H bond annulation was reported by Matsunaga. The utilization of such an approach with high valent cobalt was first reported by Ackerman and co-workers using C-2 symmetric imidazole-based chiral carboxylic acids. Later, this approach was further explored by various groups for asymmetric C–H bond functionalization using mono-dentate directing groups, where chiral carboxylic acids were used as the sole chiral source along with the Cp*Co(III)-catalytic system. Around the same time, Cramer reported the C-2 symmetric chiral Cp-ligands and their cobalt complexes in C–H bond annulation and amine transfer reactions with good yields and ee of up to 99%.

On the other hand, very recently, Shi reported an elegant method for enantioselective C–H functionalization utilizing a Co(II) salt, a bidentate directing group, and chiral salox as external ligands. In the same year, Niu and Shi reported several asymmetric C–H bond functionalizations using the same catalytic system. However, the use of stoichiometric amounts of Mn(III) is unavoidable. This was independently circumvented by the groups of Shi and Ackerman through electrochemical enantioselective C–H functionalization via anodic oxidation of Co(II) to Co(III) in the absence of metal oxidants. However, an alternative benign route by combining Co(II) with photocatalysts under oxidant-free conditions is yet to be explored for the asymmetric version. The mechanistic investigation revealed that mer-[(Sc), (Sp)-ΔCo] or mer-[(Sc)-ΔCo] is the major diastereomer among the various diastereomers in the case of phosphinamide- or benzamide-based cobaltacycles. There is a possibility that this strategy will likely be explored for asymmetric C(sp3)–H bond functionalization, perhaps possible to operate under mild conditions.

These studies further provide insights into the design of new directing groups, catalysts, and new cobalt complexes for non-directed asymmetric C–H bond functionalization with external ligands. We hope that this field has tremendous potential to improve more in the coming years and we may witness numerous transformations by judiciously altering the coordination environment of the octahedral cobalt complex.

Conflicts of interest

The authors declare no conflicts of interest.

Acknowledgements

We gratefully acknowledge SERB (CRG/2020/001282) for research funding and IITK for infrastructure. B. G. thanks PMRF & CSIR for his fellowship. A. D. and D. V. K thank CSIR for their fellowships.

Notes and references

  1. S. Murahashi, J. Am. Chem. Soc., 1955, 77, 6403–6404 CrossRef CAS.
  2. (a) J.-B. Peng, F.-P. Wu and X.-F. Wu, Chem. Rev., 2019, 119, 2090–2127 CrossRef CAS PubMed; (b) X.-F. Wu, X. Fang, L. Wu, R. Jackstell, H. Neumann and M. Beller, Acc. Chem. Res., 2014, 47, 1041–1053 CrossRef CAS PubMed; (c) Y. Li, Y. Hu and X.-F. Wu, Chem. Soc. Rev., 2018, 47, 172–194 RSC; (d) J.-B. Peng, X. Qi and X.-F. Wu, Synlett, 2017, 175–194 Search PubMed; (e) N. Rajesh, N. Barsu and B. Sundararaju, Tetrahedron Lett., 2018, 59, 862–868 CrossRef CAS.
  3. (a) I. Ojima and C.-Y. Tasi, M. Tzamaroudaki and D. Bonafoux, The Hydroformylation Reaction, 2000 DOI:10.1002/0471264180.or056.01; (b) R. Franke, D. Selent and A. Börner, Chem. Rev., 2012, 112, 5675–5732 CrossRef CAS PubMed; (c) F. Frédéric and P. Kalck, Chem. Rev., 2009, 109, 4272–4282 CrossRef PubMed.
  4. (a) P. L. Pauson and I. U. Khand, Ann. N. Y. Acad. Sci., 1977, 295, 2 CrossRef CAS; (b) J. Blanco-Urgoiti, L. Añorbe, L. Pérez-Serrano, G. Domínguez and J. Pérez-Castells, Chem. Soc. Rev., 2004, 33, 32–42 RSC; (c) S. Biswas, M. M. Parsutkar, S. M. Jing, V. V. Pagar, J. H. Herbort and T. V. RajanBabu, Acc. Chem. Res., 2021, 54, 4545–4564 CrossRef CAS PubMed.
  5. (a) C. P. Lenges and M. Brookhart, J. Am. Chem. Soc., 1997, 119, 3165–3166 CrossRef CAS; (b) K. Gao and N. Yoshikai, Acc. Chem. Res., 2014, 47, 1208–1219 CrossRef CAS PubMed.
  6. (a) Q. Chen, L. Ilies and E. Nakamura, J. Am. Chem. Soc., 2011, 133, 428–429 CrossRef CAS PubMed; (b) L. Ilies, Q. Chen, X. Zeng and E. Nakamura, J. Am. Chem. Soc., 2011, 133, 5221–5223 CrossRef CAS PubMed.
  7. (a) M. Moselage, J. Li and L. Ackermann, ACS Catal., 2016, 6, 498–525 CrossRef CAS; (b) T. Yoshino, H. Ikemoto, S. Matsunaga and M. Kanai, Angew. Chem., Int. Ed., 2013, 52, 2207–2211 CrossRef CAS PubMed; (c) L. Grigorjeva and O. Daugulis, Angew. Chem., Int. Ed., 2014, 53, 10209–10212 CrossRef CAS PubMed.
  8. (a) P. Gandeepan, T. Müller, D. Zell, G. Cera, S. Warratz and L. Ackermann, Chem. Rev., 2019, 119, 2192–2452 CrossRef CAS PubMed; (b) P. Chakraborty, R. Mandal, S. Paira and B. Sundararaju, Chem. Commun., 2021, 57, 13075–13083 RSC; (c) V. Dwivedi, D. Kalsi and B. Sundararaju, ChemCatChem, 2019, 11, 5160–5187 CrossRef CAS; (d) A. Cizikovs and L. Grigorjeva, Inorganics, 2023, 11, 194–217 CrossRef CAS.
  9. (a) N. Yoshikai, Cobalt-Catalyzed Asymmetric C–H Functionalization. In Handbook of C–H Functionalization, 2022 Search PubMed; (b) A. Gutnov, H.-J. Drexler, A. S. G. Oehme and B. Heller, Organometallics, 2004, 23, 1002–1009 CrossRef CAS; (c) R. L. Halterman, Chem. Rev., 1992, 92(5), 965–994 CrossRef CAS; (d) R. Boese, D. Bliiser, R. L. Halterman and K. P. C. Vollhardt, Angew. Chem., Int. Ed. Engl., 1988, 27, 553–555 CrossRef; (e) L. R. Halterman and K. P. C. Vollhardt, Organometallics, 1988, 7, 883–892 CrossRef; (f) R. L. Halterman, K. P. C. Vollhardt, M. E. Welker, D. Bliiser and R. Boese, J. Am. Chem. Soc., 1987, 109, 8105–8107 CrossRef CAS.
  10. B. Ye and N. Cramer, Acc. Chem. Res., 2015, 48, 1308–1318 CrossRef CAS PubMed.
  11. B. Ye and N. Cramer, Science, 2012, 338, 504–506 CrossRef CAS PubMed.
  12. (a) J. Mas-Roselló, A. G. Herraiz, B. Audic, A. Laverny and N. Cramer, Angew. Chem., Int. Ed., 2021, 60, 13198–13224 CrossRef PubMed; (b) S. Shaaban, C. Davies and H. Waldmann, Eur. J. Org. Chem., 2020, 6512–6524 CrossRef CAS.
  13. (a) C. G. Newton, D. Kossler and N. Cramer, J. Am. Chem. Soc., 2016, 138, 3935–3941 CrossRef CAS PubMed; (b) T. K. Achar, S. A. Al-Thabaiti, M. Mokhtar and D. Maiti, Chem. Catal., 2023, 3(4), 100575 CrossRef CAS.
  14. K. Ozols, Y.-S. Jang and N. Cramer, J. Am. Chem. Soc., 2019, 141, 5675–5680 CrossRef CAS PubMed.
  15. K. Ozols, S. Onodera, Ł. Woźniak and N. Cramer, Angew. Chem., Int. Ed., 2021, 60, 655–659 CrossRef CAS PubMed.
  16. A. G. Herraiz and N. Cramer, ACS Catal., 2021, 11, 11938–11944 CrossRef CAS.
  17. Y. Zheng, W.-Y. Zhang, Q. Gu, C. Zheng and S.-L. You, Nat. Commun., 2023, 14, 1094–1105 CrossRef CAS PubMed.
  18. (a) T. Yoshino and S. Matsunaga, ACS Catal., 2021, 11, 6455–6466 CrossRef CAS; (b) T. Yoshino and S. Matsunaga, Synlett, 2019, 1384–1400 CAS.
  19. (a) R. Mandal, B. Garai and B. Sundararaju, ACS Catal., 2022, 12, 3452–3506 CrossRef CAS; (b) D. Gallego and E. Baquero, OpenChem., 2018, 16, 1001–1058 CAS.
  20. (a) Y. Zheng, C. Zheng, Q. Gu and S.-L. You, Chem. Catal., 2022, 2, 2965–2985 CrossRef CAS; (b) X. Yu, Z.-Z. Zhang, J.-L. Niu and B.-F. Shi, Org. Chem. Front., 2022, 9, 1458–1484 RSC.
  21. D. Gwon, S. Park and S. Chang, Tetrahedron, 2015, 71, 4504–4511 CrossRef CAS.
  22. (a) Y.-S. Jang, M. Dieckmann and N. Cramer, Angew. Chem., Int. Ed., 2017, 56, 15088–15092 CrossRef CAS PubMed; (b) Y. Sun and N. Cramer, Angew. Chem., Int. Ed., 2018, 57, 15539–15543 CrossRef CAS PubMed.
  23. T. Yoshino, S. Satake and S. Matsunaga, Chem. – Eur. J., 2020, 26, 7346–7357 CrossRef CAS PubMed.
  24. F. Pesciaioli, U. Dhawa, J. C. A. Oliveira, R. Yin, M. John and L. Ackermann, Angew. Chem., Int. Ed., 2018, 57, 15425–15429 CrossRef CAS PubMed.
  25. T. Kurihara, M. Kojima, T. Yoshino and S. Matsunaga, Asian J. Org. Chem., 2020, 9, 368–371 CrossRef CAS.
  26. Y. H. Liu, P. P. Xie, L. Liu, J. Fan, Z. Z. Zhang, X. Hong and B.-F. Shi, J. Am. Chem. Soc., 2021, 143, 19112–19120 CrossRef CAS PubMed.
  27. Z. J. Zhang, S. W. Li, J. C. A. Oliveira, Y. Li, X. Chen, S. Q. Zhang, L. C. Xu, T. Rogge, X. Hong and L. Ackermann, Nat. Commun., 2023, 14, 3149–3157 CrossRef CAS PubMed.
  28. S. Fukagawa, Y. Kato, R. Tanaka, M. Kojima, T. Yoshino and S. Matsunaga, Angew. Chem., Int. Ed., 2019, 58, 1153–1157 CrossRef CAS PubMed.
  29. D. Sekine, K. Ikeda, S. Fukagawa, M. Kojima, T. Yoshino and S. Matsunaga, Organometallics, 2019, 38, 3921–3926 CrossRef CAS.
  30. Y. H. Liu, P. X. Li, Q. J. Yao, Z. Z. Zhang, D. Y. Huang, M. D. Le, H. Song, L. Liu and B.-F. Shi, Org. Lett., 2019, 21, 1895–1899 CrossRef CAS PubMed.
  31. Y. Hirata, D. Sekine, Y. Kato, L. Lin, M. Kojima, T. Yoshino and S. Matsunaga, Angew. Chem., Int. Ed., 2022, 61, e2022053 CrossRef PubMed.
  32. Y. B. Zhou, T. Zhou, P. F. Qian, J. Y. Li and B.-F. Shi, ACS Catal., 2022, 12, 9806–9811 CrossRef CAS.
  33. (a) Ł. Woźniak and N. Cramer, Trends Chem., 2019, 1, 471–484 CrossRef; (b) T. K. Achar, S. Maiti, S. Jana and D. Maiti, ACS Catal., 2020, 10, 13748–13793 CrossRef CAS; (c) A. Baccalini, S. Vergura, P. Dolui, G. Zanoni and D. Maiti, Org. Biomol. Chem., 2019, 17, 10119–10141 RSC.
  34. (a) T. Yoshino, Bull. Chem. Soc. Jpn., 2022, 95, 1280–1288 CrossRef CAS; (b) X.-J. Si, D. Yang, M.-C. Sun, D. Wei, M.-P. Song and J.-L. Niu, Nat., Synth., 2022, 1, 709–718 CrossRef; (c) P.-F. Qian, J.-Y. Li, Y.-B. Zhou, T. Zhou and B.-F. Shi, SynOpen, 2023, 7, 466–485 CrossRef CAS.
  35. Q. J. Yao, J. H. Chen, H. Song, F. R. Huang and B.-F. Shi, Angew. Chem., Int. Ed., 2022, 61, e202202892 CrossRef CAS PubMed.
  36. (a) S. Maity, R. Kancherla, U. Dhawa, E. Hoque, S. Pimparkar and D. Maiti, ACS Catal., 2016, 6, 5493–5499 CrossRef CAS; (b) D. Kalsi, N. Barsu and B. Sundararaju, Chem. – Eur. J., 2018, 24, 2360–2364 CrossRef CAS PubMed; (c) N. Thrimurtulu, A. Dey, D. Maiti and C. M. R. Volla, Angew. Chem., Int. Ed., 2016, 55, 12361–12365 CrossRef CAS PubMed.
  37. J. H. Chen, M. Y. Teng, F. R. Huang, H. Song, Z. K. Wang, H. L. Zhuang, Y. J. Wu, X. Wu, Q. J. Yao and B.-F. Shi, Angew. Chem., Int. Ed., 2022, 61, e202210106 CrossRef CAS PubMed.
  38. H. Meyer, J. C. A. Oliveira, D. Ghorai and L. Ackermann, Angew. Chem., Int. Ed., 2020, 59, 10955–10960 CrossRef PubMed.
  39. X. R. Chen, S. Q. Zhang, T. H. Meyer, C. H. Yang, Q. H. Zhang, J. R. Liu, H. J. Xu, F. H. Cao, L. Ackermann and X. Hong, Chem. Sci., 2020, 11, 5790–5796 RSC.
  40. B. Wang, G. Xu, Z. Huang, X. Wu, X. Hong, Q. Yao and B. Shi, Angew. Chem., Int. Ed., 2022, 61, e202208912 CrossRef CAS PubMed.
  41. D. Yang, X. Zhang, X. Wang, X.-J. Si, J. Wang, D. Wei, M.-P. Song and J.-L. Niu, ACS Catal., 2023, 13, 4250–4260 CrossRef CAS.
  42. A. Das, R. Mandal, H. Subramanian, S. Kumaran and B. Sundararaju, Angew. Chem., Int. Ed., 2024, 63, e202315005 CrossRef CAS PubMed.
  43. L. Ackermann, Acc. Chem. Res., 2020, 53, 84–104 CrossRef CAS PubMed.
  44. Y. Liu, H. Yi and A. Lei, Chin. J. Chem., 2018, 36, 692–697 CrossRef CAS.
  45. (a) T. Dalton, T. Faber and F. Glorius, ACS Cent. Sci., 2021, 7, 245–261 CrossRef CAS PubMed; (b) M. Moselage, J. Li and L. Ackermann, ACS Catal., 2016, 6, 498–525 CrossRef CAS.
  46. Y. Li, S. Dana and L. Ackermann, Curr. Opin. Electrochem., 2023, 40, 101312 CrossRef CAS.
  47. M. C. Leech and K. Lam, Acc. Chem. Res., 2020, 53, 121–134 CrossRef CAS PubMed.
  48. E. J. Horn, B. R. Rosen and P. S. Baran, ACS Cent. Sci., 2016, 2(5), 302–308 CrossRef CAS PubMed.
  49. M. Faraday, Ann. Phys., 1834, 109, 481–520 CrossRef.
  50. T. von Münchow, S. Dana, Y. Xu, B. Yuan and L. Ackermann, Science, 2023, 379, 1036–1042 CrossRef PubMed.
  51. Q.-J. Yao, F.-R. Huang, J.-H. Chen, M.-Y. Zhong and B.-F. Shi, Angew. Chem., Int. Ed., 2023, 62, e202218533 CrossRef CAS PubMed.
  52. G. Zhou, J.-H. Chen, Q.-J. Yao, F.-R. Huang, Z.-K. Wang and B.-F. Shi, Angew. Chem., Int. Ed., 2023, 62, e202302964 CrossRef CAS PubMed.
  53. Y. Lin, T. v Münchow and L. Ackermann, ACS Catal., 2023, 13(14), 9713–9723 CrossRef CAS PubMed.
  54. T. Liu, W. Zhang, C. Xu, Z. Xu, D. Song, W. Qian, G. Lu, C.-J. Zhang, W. Zhong and F. Ling, Green Chem., 2023, 25, 3606–3614 RSC.
  55. J. Wang, F. Chen, Y. Liu, Y. Liu, K. Li, X. Yang, S. Liu, X. Zhou and J. Yang, J. Nat. Prod., 2018, 81, 2722–2730 CrossRef CAS PubMed.
  56. L. S. Schwartzberg, M. R. Modiano, B. L. Rapoport, M. R. Chasen, C. Gridelli, L. Urban, A. Poma, S. Arora, R. M. Navari and I. D. Schnadig, Lancet Oncol., 2015, 16, 1071–1078 CrossRef CAS PubMed.
  57. A. Ding, M. Meazza, H. Guo, J. W. Yang and R. Rios, Chem. Soc. Rev., 2018, 47, 5946–5996 RSC.
  58. Y. Shao and D. Cheng, ChemCatChem, 2021, 13, 1271–1289 CrossRef CAS.
  59. (a) X. del Corte, E. M. de Marigorta, F. Palacios, J. Vicario and A. Maestro, Org. Chem. Front., 2022, 9, 6331–6399 RSC; (b) C. Zheng and S.-L. You, Chem, 2016, 1, 830–857 CrossRef CAS.
  60. N. Brodt and J. Niemeyer, Org. Chem. Front., 2023, 10, 3080–3109 RSC.
  61. D.-F. Chen and L.-Z. Gong, J. Am. Chem. Soc., 2022, 144, 2415–2437 CrossRef CAS PubMed.
  62. D. Parmar, E. Sugiono, S. Raja and M. Rueping, Chem. Rev., 2014, 114, 9047–9153 CrossRef CAS PubMed.
  63. W. Yuan and B.-F. Shi, Angew. Chem., Int. Ed., 2021, 60, 23187–23192 CrossRef CAS PubMed.
  64. Z.-K. Wang, Y.-J. Wu, Q.-J. Yao and B.-F. Shi, Angew. Chem., Int. Ed., 2023, e202304706 CAS.
  65. G. Bringmann, T. Gulder, T. A. M. Gulder and M. Breuning, Chem. Rev., 2011, 111, 563–639 CrossRef CAS PubMed.
  66. C. Ito, Y. Thoyama, M. Omura, I. Kajiura and H. Furukawa, Chem. Pharm. Bull., 1993, 41, 2096–2100 CrossRef CAS.
  67. S. T. Toenjes and J. L. Gustafson, Future Med. Chem., 2018, 10, 409–422 CrossRef CAS PubMed.
  68. X.-J. Si, X. Zhao, J. Wang, X. Wang, Y. Zhang, D. Yang, M.-P. Song and J.-L. Niu, Chem. Sci., 2023, 14, 7291–7303 RSC.
  69. X. Wang, X.-J. Si, Y. Sun, Z. Wei, M. Xu, D. Yang, L. Shi, M.-P. Song and J.-L. Niu, Org. Lett., 2023, 25, 6240–6245 CrossRef CAS PubMed.
  70. T. Li, L. Shi, X. Zhao, J. Wang, X.-J. Si, D. Yang, M.-P. Song and J.-L. Niu, Org. Lett., 2023, 25, 5191–5196 CrossRef CAS PubMed.
  71. T. Li, L. Shi, X. Wang, C. Yang, D. Yang, M.-P. Song and J.-L. Niu, Nat. Commun., 2023, 14, 5271–5282 CrossRef CAS PubMed.
  72. (a) O. Pamies and J.-E. Bäckvall, Chem. Rev., 2003, 103, 3247–3262 CrossRef CAS PubMed; (b) H. Pellissier, Tetrahedron, 2003, 59, 8291–8327 CrossRef CAS; (c) G. L. Thejashree, E. Doris, E. Gravel and I. N. N. Namboothiri, Eur. J. Org. Chem., 2022, e202201035 CrossRef CAS; (d) V. Bhat, E. R. Welin, X. Guo and B. M. Stoltz, Chem. Rev., 2017, 117, 4528–4561 CrossRef CAS PubMed.
  73. Y.-J. Wu, Z.-K. Wang, Z.-S. Jia, J.-H. Chen, F.-R. Huang, B.-B. Zhan, Q.-J. Yao and B.-F. Shi, Angew. Chem., Int. Ed., 2023, 62, e202310004 CrossRef CAS PubMed.

This journal is © The Royal Society of Chemistry 2024
Click here to see how this site uses Cookies. View our privacy policy here.